{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Under pressure from experts in birth defects, the Food and Drug Administration today withdrew, at least for now, a new rule that allowed dietary supplements to be sold for common pregnancy-related conditions like morning sickness and leg swelling. Unlike drugs, supplements do not require rigorous testing for safety and efficacy, and the new F.D.A. rule, which took effect on Monday, drew fire from birth defects experts, who said it would put unborn babies at risk.", "headline": {"main": "F.D.A. Bars Marketing of Supplements to Pregnant Women"}, "abstract": "Food and Drug Administration, under pressure from experts in birth defects, withdraws new rule that allows dietary supplements to be sold for common pregnancy-related conditions like morning sickness (M)", "print_page": "28", "word_count": 540, "_id": "4fd210ed8eb7c8105d785ada", "snippet": "Under pressure from experts in birth defects, the Food and Drug Administration today withdrew, at least for now, a new rule that allowed dietary supplements to be sold for common pregnancy-related conditions like morning sickness and leg swelling.   ...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/02/10/us/fda-bars-marketing-of-supplements-to-pregnant-women.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "PEAR, ROBERT"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "BIRTH DEFECTS"}, {"name": "subject", "value": "PREGNANCY AND OBSTETRICS"}, {"name": "subject", "value": "DIETARY SUPPLEMENTS AND HERBAL REMEDIES"}], "byline": {"person": [{"firstname": "Sheryl", "middlename": "Gay", "lastname": "STOLBERG", "rank": 1, "role": "reported", "organization": ""}], "original": "By SHERYL GAY STOLBERG"}, "document_type": "article", "pub_date": "2000-02-10T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "With her official declaration for the United States Senate behind her, Hillary Rodham Clinton flew into a region of New York today that is likely to be a prime battleground in the race this fall, turning her attention to what has long been a dominant concern among voters here: the region's long-suffering economy. With President Clinton back in Washington, the first lady moved to settle into life as just another candidate running for public office. She gave the first of what aides said would be five speeches between today and Friday, this one offering measures to spur economic growth here, including about $550 million worth of tax incentives and grants to encourage Internet development. She granted three one-on-one interviews with reporters, a notable break with her more cloistered first seven months of traveling the state. She visited a part of New York where Democratic candidates for office always campaign.", "headline": {"main": "Mrs. Clinton Turns Focus to Plans to Ease Upstate Economic Troubles"}, "abstract": "Hillary Rodham Clinton, with her official declaration for United States Senate behind her, campaigns in Cheektowaga, NY; offers measures aimed at spurring economic growth, including about $550 million in tax incentives and grants to encourage Internet development (M)", "print_page": "8", "word_count": 982, "_id": "4fd237718eb7c8105d7c9b46", "snippet": "With her official declaration for the United States Senate behind her, Hillary Rodham Clinton flew into a region of New York today that is likely to be a prime battleground in the race this fall, turning her attention to what has long been a dominant...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/02/08/nyregion/mrs-clinton-turns-focus-to-plans-to-ease-upstate-economic-troubles.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CLINTON, HILLARY RODHAM"}, {"name": "glocations", "value": "NEW YORK STATE"}, {"name": "glocations", "value": "CHEEKTOWAGA (NY)"}, {"name": "organizations", "value": "SENATE"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "TAX DEDUCTIONS"}, {"name": "subject", "value": "ELECTIONS"}, {"name": "subject", "value": "ECONOMIC CONDITIONS AND TRENDS"}, {"name": "subject", "value": "COMPUTERS AND THE INTERNET"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Adam", "lastname": "NAGOURNEY"}], "original": "By ADAM NAGOURNEY"}, "document_type": "article", "pub_date": "2000-02-08T00:00:00Z", "section_name": "Technology; New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "In less than four years, the euphoria over the success of new drug combinations to treat AIDS has yielded to the sobering challenge of dealing with the drugs' complications and failures. Death rates for what had been an invariably fatal disease have dropped significantly since the introduction of combinations of protease inhibitors and other drugs. Many people with H.I.V., the AIDS virus, including some who were near death when they began taking the drug combinations in 1996, continue to lead more or less normal lives, though they must take a number of pills at specified times throughout the day, at costs that can exceed $10,000 a year.", "headline": {"main": "Promise And Peril Of New Drugs For AIDS", "kicker": "THE DOCTOR'S WORLD"}, "abstract": "Earlier optimism about new drug combinations to treat AIDS is absent from recent international conference, San Francisco, in face of challenge of dealing with drugs' complications and failures and spread of infection through many parts of world; major cause of drug failure is HIV virus's ability to mutate to become drug resistant; early-stage research indicates potent new drugs could eventually be developed; photo (M)", "print_page": "1", "word_count": 1644, "_id": "4fd233bf8eb7c8105d7c436d", "snippet": "In less than four years, the euphoria over the success of new drug combinations to treat AIDS has yielded to the sobering challenge of dealing with the drugs' complications and failures.    Death rates for what had been an invariably fatal disease...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2000/02/08/science/the-doctor-s-world-promise-and-peril-of-new-drugs-for-aids.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Lawrence", "middlename": "K.", "lastname": "ALTMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By LAWRENCE K. ALTMAN, M.D"}, "document_type": "article", "pub_date": "2000-02-08T00:00:00Z", "section_name": "Science; Health"}], "meta": {"hits": 3, "offset": 0, "time": 44}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}